Atlanta, GA, United States of America

Mary M Hulihan

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Eberhard Karls Universitaet Tuebingen, Mayo Foundation for Medical Education and Research, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary M Hulihan. Retrieved from https://idiyas.com/inventor/mary-m-hulihan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile




Average Co-Inventor Count = 17.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mary M. Hulihan: Innovator in Neurodegenerative Disorder Research

Introduction

Mary M. Hulihan is a prominent inventor based in Atlanta, GA, known for her significant contributions to the field of neurodegenerative disorders. With a total of two patents to her name, she has made remarkable strides in understanding and treating conditions such as Parkinson's disease and Alzheimer's disease.

Latest Patents

Her latest patents focus on the KASPP (LRRK2) gene, which is crucial for the detection and treatment of neurodegenerative disorders. The invention details the production, biochemical characterization, and application of the KASPP gene, also known as LRRK2 (Leucine-Rich Repeat Kinase 2). This gene is associated with various neurodegenerative conditions, including sporadic Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related disorders. The research highlights several polymorphisms and mutations in the KASPP/LRRK2 gene that are linked to Parkinson's disease.

Career Highlights

Mary has worked with esteemed institutions such as Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. Her work has been instrumental in advancing the understanding of genetic factors in neurodegenerative diseases.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom. These partnerships have further enriched her research and contributions to the field.

Conclusion

Mary M. Hulihan's innovative work in the realm of neurodegenerative disorders showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving the lives of those affected by these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…